tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 1.59, suggesting Basilea Pharmaceutica is a Sell.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 50.98, while Basilea Pharmaceutica’s (BSLN) share price is CHF53.2, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 49.34, while Basilea Pharmaceutica’s (BSLN) share price is CHF53.2, making it a Buy.

Basilea Pharmaceutica (BSLN) Pivot Points

Dec 19, 2025, 03:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.00
52.80
53.20
54.00
54.40
55.20
55.60
Fibonacci
52.80
53.26
53.54
54.00
54.46
54.74
55.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Dec 19, 2025, 03:17 AM
Period
Simple
Exponential
MA5
53.34Sell
53.14Buy
MA10
52.48Buy
52.34Buy
MA20
50.50Buy
50.98Buy
MA50
48.55Buy
49.34Buy
MA100
48.66Buy
48.62Buy
MA200
47.74Buy
47.13Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 52.34, while Basilea Pharmaceutica’s (BSLN) share price is CHF53.2, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 48.62, while Basilea Pharmaceutica’s (BSLN) share price is CHF53.2, making it a Buy.
Basilea Pharmaceutica’s (BSLN) stock price is CHF53.2 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 48.55, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF53.2 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 48.66, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF53.2 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 47.74, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Dec 19, 2025, 03:17 AM
Name
Value
Implied Action
RSI (14)
69.16
Neutral
STOCH (9,6)
78.06
Neutral
STOCHRSI (14)
85.47
Sell
MACD (12,26)
1.59
Sell
ADX (14)
31.23
Neutral
Williams %R
-25.00
Buy
CCI (14)
95.65
Neutral
ATR (14)
1.11
-
Ultimate Oscillator
57.19
Neutral
ROC
9.24
Buy
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 69.16, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 31.23, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is 95.65, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is 9.24, creating a Buy signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Buy.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 69.16, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 1.59, which suggests BSLN is a Sell.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 53.34, which suggests BSLN is a Sell.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 50.50, which suggests BSLN is a Buy.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 48.55, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 47.74, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -25.00, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is 95.65, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?